Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

<![CDATA[9 Drugs Approved for Primary Care: Q3 2026]]>
Дата публикации: 06-10-2026 20:02:02



Основное содержимое страницы с новостью.

News|Slideshows|October 6, 2026

Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.

An oral PCSK9 inhibitor for hypercholesterolemia and a once-weekly basal insulin for type 2 diabetes were among the FDA approvals with direct relevance to primary care in the third quarter of 2026. The decisions also expanded options for ADHD, contraception, influenza prevention, HIV treatment, narcolepsy, and pain relief.

Related to this article

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1<![CDATA[5 FDA Decisions for Primary Care to Know from September 2026]]>017.5801-10-2026
2<![CDATA[Building Clinician Confidence to Prescribe HIV PrEP in Primary Care]]>06.2514-10-2026
3<![CDATA[Starting the HIV PrEP Conversation in Primary Care and Pharmacy]]>06.2307-10-2026
4U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir014.7229-04-2026
5Apnimed Announces FDA Acceptance of New Drug Application for AD109, An Investigational Oral Pill to Treat Adults with Obstructive Sleep Apnea014.5614-07-2026
6Россиянам с ВИЧ добавили новых лекарств021.1617-08-2026
7<![CDATA[Who Should Get a CGM? Expanding the Primary Care Candidate Pool]]>08.8614-10-2026
8<![CDATA[FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test]]>012.6614-10-2026
9FDA approves first OTC combo of Tylenol and Naproxen for 'non-opioid' pain relief010.3329-07-2026
10FDA approves first OTC combo of Tylenol and Naproxen for 'non-opioid' pain relief010.3301-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 16.53. Источник: www.patientcareonline.com.